David I Sandberg, MD
The University of Texas Health Science Center, Houston
2
2
2
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Donald W Parsons
Children's Oncology Group
Shared therapeutic areas:
Andrea T Franson
Children's Oncology Group
Shared therapeutic areas:
Matthias Karajannis, MD, MS
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Meredith S Irwin
Children's Oncology Group
Shared therapeutic areas:
Susan N Chi
Children's Oncology Group
Shared therapeutic areas:
Elizabeth D Alva
Children's Oncology Group
Shared therapeutic areas:
Brian Rood, MD
Children's National Research Institute
Shared therapeutic areas:
Soumen Khatua
M.D. Anderson Cancer Center
Shared therapeutic areas:
Katherine A Janeway
Children's Oncology Group
Shared therapeutic areas:
Jeffrey M. Treiber, MD
The University of Texas Health Science Center, Houston
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma
Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma
All 2 trials loaded